Shilpa Medicare Limited informed that on the recommendation of the Nomination and Remuneration Committee, the Board of Directors, by way of circular resolution passed on July 01, 2022, have approved the appointment of Dr. Kamal K Sharma (DIN: 00209430), as an Additional Independent Director on the Board of the Company, with effect from July 01, 2022, to hold office upto the ensuing 35th Annual General Meeting of the Company. Dr. Kamal K Sharma (DIN: 00209430), aged 74 yrs, is Vice Chairman of Lupin Limited. In a successful career spanning more than four decades, Dr. Sharma has held a range of senior management positions managing operations, corporate development and executive management within the pharmaceuticals and chemicals industries.

Dr. Sharma is presently the Non-Executive Vice-Chairman of Lupin. As the Managing Director of Lupin (from 2003 to Sept., 2013) he has been responsible for shaping and inking Lupin's stupendous success; one of the architects of Lupin having achieved market leadership in key markets and businesses globally; transforming it into one of the largest and fastest growing pharmaceutical companies globally. Beginning October 2013, he was elevated to the position of Executive Vice Chairman, which he held till September 2018.

Since 2018 he continues on the Board of the company as non-executive Vice Chairman and Director. Dr. Sharma also served as the President and Chief Executive of the life sciences and specialty group and member of the management board at RPG Enterprises Ltd, Mumbai. Dr. Sharma is a chemical engineer from Indian Institute of Technology (IIT), Kanpur, with a post- graduate diploma in industrial management from Jamnalal Bajaj Institute of Management Studies, Mumbai, and a Ph.D. in economics from IIT, Mumbai.

He also holds an advanced management degree from the Harvard Business School, Boston.